Altrartis Therapeutics Form D (2026)
Altrartis Therapeutics reported $10,999,977 raised in an SEC Form D filed on 2026-10-22.
- Company
- Altrartis Therapeutics
- Round type
- Form D
- Date
- 2026-10-22
- Amount
- $11M
- Industry
- Other
- Location
- New York
Summary
The SEC Form D for Altrartis Therapeutics, filed on 2026-10-22, reports $10,999,977 raised. The legal name on the form is Altrartis Therapeutics Inc. The form does not name the purchasers. Filing: https://www.sec.gov/Archives/edgar/data/2157050/000123191926001488/0001231919-26-001488-index.htm
This is the issuer's first Form D in the EDGAR submissions list read here.
This page is not indexed by search engines yet because the filing does not name the purchasers.
Investors
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2157050/000123191926001488/0001231919-26-001488-index.htm
Type: sec filing. Accessed 2026-10-26.
SEC Form D for Altrartis Therapeutics Inc. EDGAR filing date 2026-10-22. Signed 2026-10-22 by Florian Brand. First sale 2026-08-12. Total amount sold $10,999,977 of an offering amount of $10,999,977. 11 investors already invested. Issuer address city is New York, New York. Jurisdiction on the form: Delaware. Year of incorporation on the form: 2025. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. The form describes the securities as equity. This is the issuer's first Form D in the EDGAR submissions list read here.